Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 345

1.

CB receptor ligands from plants.

Woelkart K, Salo-Ahen OM, Bauer R.

Curr Top Med Chem. 2008;8(3):173-86. Review.

PMID:
18289087
2.

Therapeutic potential of cannabinoids in CNS disease.

Croxford JL.

CNS Drugs. 2003;17(3):179-202. Review.

PMID:
12617697
3.
4.

New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors.

Gertsch J, Raduner S, Altmann KH.

J Recept Signal Transduct Res. 2006;26(5-6):709-30. Review.

PMID:
17118807
5.

The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.

Correa F, Mestre L, Molina-Holgado E, Arévalo-Martín A, Docagne F, Romero E, Molina-Holgado F, Borrell J, Guaza C.

Mini Rev Med Chem. 2005 Jul;5(7):671-5. Review.

PMID:
16026313
6.

The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.

McCarberg BH, Barkin RL.

Am J Ther. 2007 Sep-Oct;14(5):475-83. Review.

PMID:
17890938
7.

Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?

Oesch S, Gertsch J.

J Pharm Pharmacol. 2009 Jul;61(7):839-53. doi: 10.1211/jpp/61.07.0002. Review.

PMID:
19589225
8.

Cannabinoid receptors and their ligands.

Pertwee RG, Ross RA.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):101-21. Review.

PMID:
12052030
9.

Cannabinoid system and neuroinflammation: implications for multiple sclerosis.

Correa F, Docagne F, Mestre L, Loría F, Hernangómez M, Borrell J, Guaza C.

Neuroimmunomodulation. 2007;14(3-4):182-7. Review.

PMID:
18073512
10.

Cannabinoids for gastrointestinal diseases: potential therapeutic applications.

Di Carlo G, Izzo AA.

Expert Opin Investig Drugs. 2003 Jan;12(1):39-49. Review.

PMID:
12517253
11.

Pharmacology of cannabinoids.

Grotenhermen F.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):14-23. Review.

PMID:
15159677
12.

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.

Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R.

Trends Pharmacol Sci. 2009 Oct;30(10):515-27. doi: 10.1016/j.tips.2009.07.006. Review. Erratum in: Trends Pharmacol Sci. 2009 Dec;30(12):609.

PMID:
19729208
13.

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.

Rice AS, Farquhar-Smith WP, Nagy I.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):243-56. Review.

PMID:
12052040
14.

Cannabinoid receptors and pain.

Pertwee RG.

Prog Neurobiol. 2001 Apr;63(5):569-611. Review.

PMID:
11164622
15.

Cannabis and the brain.

Iversen L.

Brain. 2003 Jun;126(Pt 6):1252-70. Review.

16.

Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.

Burns TL, Ineck JR.

Ann Pharmacother. 2006 Feb;40(2):251-60. Review.

PMID:
16449552
17.

Basic neuroanatomy and neuropharmacology of cannabinoids.

Breivogel CS, Sim-Selley LJ.

Int Rev Psychiatry. 2009 Apr;21(2):113-21. doi: 10.1080/09540260902782760. Review.

PMID:
19367505
18.

An overview on the biochemistry of the cannabinoid system.

Gómez-Ruiz M, Hernández M, de Miguel R, Ramos JA.

Mol Neurobiol. 2007 Aug;36(1):3-14. Review.

PMID:
17952645
19.

Phytocannabinoids and endocannabinoids.

Fisar Z.

Curr Drug Abuse Rev. 2009 Jan;2(1):51-75. Review.

PMID:
19630737
20.

The cannabinoid system and immune modulation.

Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H.

J Leukoc Biol. 2003 Oct;74(4):486-96. Review.

PMID:
12960289
Items per page

Supplemental Content

Support Center